Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Sluggish growth in US, demonetisation & GST slow down pharma market

Aggregate revenues of 21 leading firms grew by 7.4% in FY2017 compared to 10.1% in FY2016, says ICRA

Topics
Pharmaceuticals

BS B2B Bureau  |  Mumbai 

Indian pharmaceutical industry continue to face growth challenges with aggregate growth of the industry expected to come down to single digit, according to ICRA. The growth trajectory for Indian pharmaceutical industry is likely to be moderate on back of slowing growth from US given the relatively moderate proportion of large size drugs going off patent, increased competition leading to price erosion in high single digits to low teens, generic adoption reaching saturation levels and, regulatory overhang along with base effect catching up. Gaurav Jain, vice president & co-head, ...

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, July 03 2017. 14:47 IST
RECOMMENDED FOR YOU

Sluggish growth in US, demonetisation & GST slow down pharma market

Aggregate revenues of 21 leading firms grew by 7.4% in FY2017 compared to 10.1% in FY2016, says ICRA

Aggregate revenues of 21 leading firms grew by 7.4% in FY2017 compared to 10.1% in FY2016, says ICRA Indian pharmaceutical industry continue to face growth challenges with aggregate growth of the industry expected to come down to single digit, according to ICRA. The growth trajectory for Indian pharmaceutical industry is likely to be moderate on back of slowing growth from US given the relatively moderate proportion of large size drugs going off patent, increased competition leading to price erosion in high single digits to low teens, generic adoption reaching saturation levels and, regulatory overhang along with base effect catching up. Gaurav Jain, vice president & co-head, ... image
Business Standard
177 22

Sluggish growth in US, demonetisation & GST slow down pharma market

Aggregate revenues of 21 leading firms grew by 7.4% in FY2017 compared to 10.1% in FY2016, says ICRA

Indian pharmaceutical industry continue to face growth challenges with aggregate growth of the industry expected to come down to single digit, according to ICRA. The growth trajectory for Indian pharmaceutical industry is likely to be moderate on back of slowing growth from US given the relatively moderate proportion of large size drugs going off patent, increased competition leading to price erosion in high single digits to low teens, generic adoption reaching saturation levels and, regulatory overhang along with base effect catching up. Gaurav Jain, vice president & co-head, ...

image
Business Standard
177 22